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A B S T R A C T
The purpose of the study was to evaluate whether there is a difference between blood pressure measured in a physi-
cian’s office and the average 24hr continuous blood pressure monitored by hypertensive patients at home. If there is a dif-
ference between these two situations then is it possibly the result of a blood pressure response by the patient to the physi-
cian which is known as »white coat effect« or »white coat hypertension«. We studied 80 hypertensive outpatients which
were divided into two groups of 40 patients each – a younger patient group, with a mean age of 22.8 ± 1.8 years, and an
older patient group with a mean age of 50.3 ± 5.7 years. They were selected because they had been diagnosed as essen-
tially hypertension grade 1, according to 2007 ESH/ESC Guidelines, or the USA Joint National Committee Guidelines
(JNC 7) (i.e., arterial blood pressure > 140/90 mm Hg and <160/100 mmHg) and 35 were not having any antihyper-
tensive treatment. All participants in the study went through a two-week »wash-out« period without medication. At the
beginning of the study blood pressure was measured using the Riva-Rocci-Korotkoff method (mercury sphygmomanome-
ter) after 5 minutes of rest and with the patient in the sitting position. The average of the two last measurements by sphyg-
momanometer was used in the analysis. The subsequent measurement was made by continuous ambulatory blood pres-
sure monitoring (SpaceLabs 90207 device). Continuous ambulatory blood pressure monitoring revealed that 17 patients
of the younger age group (42.5%) who were diagnosed hypertonic, according to mercury sphygmomanometeric measure-
ment, were in fact normotonic. In the older age group only 7 (17.5%) of participants were normotonic during 24hr blood
pressure monitoring. The proportion of miss-diagnosed normotonic younger patients was directly related to elevated
clinic blood pressure, which could be referred to as office hypertension or isolated clinic hypertension (white coat hyper-
tension). This was statistically significant (c2=5.95; p=0.015). Hypertension diagnosed in younger patients based only
on occasional doctor’s office mesuraments, using a mercury sphygmomanometer, could be miss-interpreted and treated
as the start of arterial hypertension. This could sometimes have unwanted results due to the side effects of precipitate
antihypertensive medication as well as the unnecessary cost of testing, cost of treatment, prevalence of white-coat hyper-
tension at baseline, and the varying incidence of new hypertension after the initial screening. The results indicate a po-
tential savings of 3–14% in the cost of care for hypertension, and a 10–23% reduction in treatment days when ambulatory
blood pressure monitoring is incorporated into the diagnostic process11. Therefore CABPM should be used as a legitimate
method in the diagnosing of »white coat hypertension«, particularly in young patients. The identification of »white coat
hypertensive«’ patients should be followed by a search for metabolic risk or organ damage using the latest guidelines,
and medication should start after an organ damage or cardiovascular risk assesement2,5,6.
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Introduction
Arterial hypertension is one of the major risk factors
for cardiovascular diseases. The prevalence of hyperten-
sion varies from 10–20% and it depends on the level of ar-
terial blood pressure which is defined as hypertensive1–3.
The fact is that the prevalence of hypertension has socio-
economic and medical importance4 because hypertension
is present in the majority of other cardiovascular dis-
eases (myocardial infarction, heart failure, cerebral in-
sult and renal diseases) and for 30% of patients it is a di-
rect cause of death2,4–6. The lowest mortality rate is
found in people with systolic blood pressure (BP) be-
tween 110–120 mm Hg and diastolic BP between 70–80
mm Hg and it increases with the deviations of these val-
ues. High prevalence of hypertension in well-developed
countries, as well as the fact that its treatment signifi-
cantly lowers the risk for cardiovascular complications,
imposes the control of this risk factor as a priority objec-
tive of the health service. Persistent arterial hyperten-
sion (arterial blood pressure  140/90 mm Hg) is diag-
nosed only after repeated measurements of arterial blood
pressure which can be done (a) at home, (b) at a physi-
cian’s office, or (c) by ambulatory blood pressure moni-
toring2,6.
Continuous ambulatory BP recordings give more re-
producible values over fairly long periods of time com-
pared with the doctor’s office BP7–9. Continuous ambula-
tory blood pressure monitoring (CABPM) is proven to be
reliable and gives a more valid image of the vascular
weight of hypertension than a small number of BP read-
ings in the physician’s office7–10,13, but due to technical
and economic reasons it isn’t used as much as it should
be in hypertonic patients. Although the accurate diagno-
sis of hypertension and prognosis for future cardiovascu-
lar events can be enhanced through the use of 24hr am-
bulatory blood pressure monitoring10–13.
A hypertension is usually diagnosed on the basis of re-
peated standard BP measurements by the Riva-Rocci-
-Korotkoff method (mercury sphygmomanometer) at a
physician’s office when BP values are equal to or greater
than 140/90 mm Hg2,6. As the evaluation of persistent hy-
pertension is done on the basis of arterial blood pressure
measurements at home or at physician’s office (instead
of multiple BP measurements taken on several separate
occasions over a period of time, for older age groups
within 2 or 3 weeks, and for younger age groups with di-
etary restrictions within a few months), this may cause
errors in the hypertension diagnosing which include:
false hypertension, white coat hypertension, mask hy-
pertension, alert reaction and the consequential unnec-
essary and potentially dangerous antihypertensive treat-
ment.
The purpose of the present study was to evaluate
whether there is a difference between blood pressure
measured in the physician’s office and the average 24hr
continuous blood pressure in hypertensive patients mon-
itored at the patients’ home, and if there is a difference,
could it be the result of possible blood pressure response
of the patient to the physician known as »white coat ef-
fect« or »white coat hypertension«14–17.
Participants and Methods
The study included 80 outpatients divided in two
groups each of 40. A younger age group (26 men and 14
women) and an older age group (21 men and 19 women)
with an average age range of the younger group (mean ±
SD age, 22.8 ± 1.8 years) and the older group (mean ± SD
age, 50.3 ± 5.7 years). The patients consented to the pro-
cedure after they were told that their blood pressure was
going to be measured using different techniques and all
the procedures were explained to them.
They were selected if they had been diagnosed as es-
sential hypertension grade 1, according to 2007 ESH/
ESC Guidelines or The USA Joint National Committee
Guidelines (JNC 7) (i.e., arterial blood pressure > 140/90
mm Hg and <160/100 mmHg), and without antihyper-
tensive treatment. All participants went through a two-
week »wash-out« period without medication.
All patients underwent different clinical examina-
tions essential for this study. Demographic information
collected on each patient included sex, age, reported fam-
ily history of hypertension and risk factors – alcohol con-
sumption, habitual cigarette smoking as well as physical
activity. Target organ damage in all patients was clini-
cally evaluated. All patients underwent electrocardio-
gram and direct fundoscopy. Anthropometric measure-
ments included height and weight and calculation of
body mass index (BMI; kg/m²). Biochemical measure-
ments included total cholesterol, creatinin and blood glu-
cose levels and proteinuria. Arterial blood pressure was
measured with a mercury sphygmomanometer three
consecutive times in a sitting position after 5 minutes of
patient rest. The average of the last two measurements
was used in the analysis. Heart rate was also collected.
The patients were subsequently fitted with a non-inva-
sive device (SpaceLabs, Medical 90207) for ambulatory
blood pressure monitoring, which they wore for the next
24 hours (from 0800 that day until 0800 the next day).
The average blood pressure obtained from CABPM of
140 mm Hg for systolic and 90 mm Hg for diastolic blood
pressure was defined as hypertension.
The study protocol was approved by the ethics com-
mittee of the institutions involved. Statistical analysis
was done using SPSS software. Comparison of quantita-
tive values was made using t-test if they did not show sig-
nificant differences from the average. If the data showed
significant differences from average values then the
Mann-Whitney test was used. To compare quantitative
variables between four groups we used analysis of vari-
ance or Kruskal-Wallis test. After analysis of variance, to
compare two groups, we further used Tukey HSD test,
and after Kruskal-Wallis analysis of variation we used
the Mann-Whitney test. The data within each group was
analysed using the Wilcoxon test. For qualitative data
analysis we used c² test. Only a p<0.05 is considered as
statistically significant.
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Results
The 80 patients examined for this study, were divided
in two groups – 40 of them in a younger age group (aged
20 to 25,average 22.8 ± 1.8 years) and 40 in an older age
group (aged 40–60 years, average 50,3 ± 5,7). Patients in
the younger age group were more physically active (c2=
20.05; p<0.001). Patients in the older age group had
greater weight (t = 2.880; p=0.0051) and BMI (t = 2.966;
p=0.0040). The younger patients had normal electrocar-
diogram and fundus, while 6 patients in the older age
group had electrocardiograms showing signs of left ven-
tricular hypertrophy (c2=6.49; p=0.0109) and 13 of them
had fundus hypertensive changes (c2=15,52; p<0,001).
Cholesterol levels in the older age group were signifi-
cantly higher (t = 3.698; p=0.0004)) and more of the
older patients had proteinuria (c2=5.46; p=0.0195). The
systolic BP in the older age group was higher than in the
younger group (t = 2.281; p=0.0252) See Table 2. All
other parameters taken were equal for both groups and
thus statistical not significant (Table 1 and Table 2).
According to the CABPM readings in our study, 23 pa-
tients in the younger age group and 33 patients in the
older age group were diagnosed as being hypertensive
(c²=5.95; p=0.015) (Table 3). The difference between
blood pressure values obtained by standard mercury
sphygmomanometer and CABPM can be seen by analys-
ing the differences in systolic and diastolic blood pres-
sure (Table 4, Figure 1 and 2).
The difference in systolic blood pressure was signifi-
cant in the younger age group patients who were ex-
cluded from having hypertension by CABPM (26.4 ± 10.1
mm Hg; z=3.6; p<0.001) (Table 1, Figure 1) as well as
the difference in diastolic blood pressure (25.2 ± 7.9 mm
Hg; z=3.6; p<0.001) (Table 1, Figure 2).
There was a significant differences in systolic blood
pressure in patients aged under 40, who were diagnosed
by CABPM as having arterial hypertension (18.9 ± 12.5
mm Hg; z=4.1; p<0.001) (Table 4, Figure 1). A minor
drop in systolic blood pressure observed among young
hypertensive patients by CABPM is of borderline signifi-
cance (z=1.99; p=0.05) compared to the considerable
drop in diastolic blood pressure (z=5.0; p<0.001).
CABPM recorded the drop of systolic (30.0 ± 9.6 mm Hg;
z=2.37; p=0.018) (Table 4, Figure 1), and diastolic blood
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TABLE 1
CHARACTERISTICS OF PARTICIPANTS BEFORE FIRST BLOOD PRESSURE MEASUREMENT
Characteristics 20–25 years 40–60 years Test; p
Age 22.8 ± 1.8 50.3 ± 5.7 t=29.10; p<0,001
Smonking positive, n 32 25 c2=2.99; p=0.0838
Physical activity positive, n 31 11 c2=20.05; p<0.001
Weight, kg 74.4 ± 12.2 82.4 ± 12.6 t = 2.880; p=0.0051
Height, cm 173.2 ± 7.9 174.3 ± 6.8 t = 0.667; p=0.5065
BMI, kg/m2 24.8 ± 3.1 27.1 ± 3.8 t = 2.966; p=0.0040
LVH, n 0 6 c2=6.49; p=0.0109
Hypertensive fundus, n 0 13 c2=15,52; p<0,001
Creatinin, mol/L 96.5 ± 19.9 101.7 ± 20.7 t = 1.145; p=0.2556
Cholesterol, mmol/L 5.2 ± 1.4 6.4 ± 1.5 t = 3.698; p=0.0004
Glucose, mmol/L 4.7 ± 0.97 4.64 ± 1.14 t = 0.253; p=0.8005
Proteinuria 2 9 c2=5.46; p=0.0195
Heart rate 77.5 ± 8.7 76.9 ± 8.0 t = 0.321; p=0.7490
TABLE 2
BLOOD PRESSURE VALUES MEASURED ACCORDING TO THE RIVA-ROCCI-KOROTKOFF METHOD
(MERCURY SPHYGMOMANOMETER) – FIRST MEASUREMENT
Characteristics 20–25 years
Systolic BP, mm Hg 157.6 ± 13.1 164.5 ± 13.8 t = 2.281; p=0.0252
Diastolic BP, mm Hg 101.6 ± 6.2 101.4 ± 6.6 t = 0.139; p=0.8893
TABLE 3
THE »TRUE« HYPERTENSION DIAGNOSIS BETWEEN YOUNGER










No 17 7 24
Yes 23 33 56
Total 40 40 80
pressure (19.3 ± 6.1 mm Hg, z=2.37; p=0.019) (Table 4,
Figure 2) in the older age group who were excluded from
having arterial hypertension, as well as in those diag-
nosed as hypertensive. Among those patients the differ-
ence in the drop in systolic blood pressure (13.2 ± 16.2
mm Hg; z=3.84; p<0.001) (Table 4, Figure 1) and dia-
stolic blood pressure (6.2 ± 7.2 mm Hg; z=3.84; p<0.001)
(Table 4; Figure 2) is less but still statistically significant
for systolic (z= 2.5; p=0.012) and for diastolic blood pres-
sure (z=4.5; p=0.001).
Discussion
It is well known that office or clinic blood pressure
measurements are performed in inadequate circum-
stances although the recommendations are that it should
be done in a quiet comfortable environment and after a
patient has been relaxing for a few minutes2,6. These con-
ditions are hard to achieve in clinical practice because pa-
tients often wait a long time for a medical examination
and they can feel very tense. When they finally reach the
physician’s office the blood pressure measurement is
usually done very quickly and therefore the physician
measures a considerably higher blood pressure due to
time pressures and a backlog of patients. That can result
in elevated blood pressure values up to 27/15 mm Hg and
it does not change with repeated measurements 8. Al-
though arterial hypertension should be diagnosed on the
basis of several separate blood pressure measurements
over a period of a few weeks, this does not happen. A pa-
tient could be diagnosed as hypertensive after only one
blood pressure measurement and as a consequence ad-
ministered antihypertensive medications and ordered to
return for a check up within a few months. This could
sometimes have unwanted results due to the side effects
of precipitate antihypertensive medication as well as the
unnecessary cost of testing, cost of treatment, prevalence
of white-coat hypertension at baseline, and the varying
incidence of new hypertension after the initial screening.
The results indicate a potential savings of 3–14% in the
cost of care for hypertension and a 10–23% reduction in
treatment days where ambulatory blood pressure moni-
toring is incorporated into the diagnostic process11,12.
The continuous ambulatory blood pressure monitoring
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TABLE 4
BLOOD PRESSURE VALUES MEASURED WITH A MERCURY SPHYGMOMANOMETER AND BY ABPM AMONG
DIFFERENT GROUPS OF PATIENTS
Systolic BP*, measured



























































* BP = blood pressure (mm Hg) ** CABPM = ambulatory blood pressure monitoring
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Fig. 2. Dyastolic arterial blood pressure measured with a mer-
cury sphygmomanometer and by CABPM.
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Fig. 1. Systolic arterial blood pressure measured with a mercury
sphygmometer and by CABPM (BP = blood pressure, CABPM =
ambulatory blood pressure monitoring).
(CABPM) is indispensable in avoiding hyper diagnosing
of arterial hypertension continuous17–20.
When office blood pressure is persistently elevated
and daytime, or 24-hour blood pressure, or home blood
pressure, are within their normal range, according to the
latest 2007 ESH/ESC Guidelines, this condition is known
as »white coat hypertension« (WCH)14. Although the
more descriptive and less mechanistic term »isolated of-
fice (or clinic) hypertension« is preferable because the of-
fice ambulatory blood pressure difference does not corre-
late with the office blood pressure elevation induced by
the alerting response to a doctor or a nurse, that is the
true »white coat effect«6.
The rise of the arterial blood pressure above 140/90
mm Hg is noted in the first and last hour of monitoring.
The rise of blood pressure is somewhat higher in hyper-
tensive than normotensive patients16,17.
Clinical studies have shown the prevalence to be
10–20%15 and can even be up to 60%22,23 and in this study
the prevalence of white coat hypertension is shown to be
even greater.
Some studies have tried to establish the correlation
between white coat hypertension and metabolic dysfunc-
tion (hyperlipidemy?) and obesity24. In our study the
older group of patients showed statistically greater BMI
then the younger group.
It is known that short term physical activity does not
have a significant effect on arterial blood pressure within
younger normotensive people if measured throughout 24
hours25,28. In our study there was a significant difference
in the age of the patients and also in changes in electro-
cardiogram and fundus (atherosclerosis or hypertensive
of 1 degree)26,27. The results of recent arterial blood pres-
sure measurements indicate that electrocardiogram and
echo sonogram of healthy normotensive people and whi-
te coat hypertensive does not differ much27,29. In some
studies, left ventricular hypertrophy reached a propor-
tion of 10%30. Because of all these reasons some authors
recommend the use of CABPM in all newly diagnosed hy-
pertensive patients10,14,16,17 and the use of echocardio-
gram in borderline hypertensives. Unfortunately, this
practice is possible only in countries with larger health
care budgets than the average11,31.
The continuous ambulatory blood pressure monitor-
ing revealed that 17 patients of the younger age group
(42.5%) who were diagnoses hypertonic according to
mercury sphygmomanometeric measurement were nor-
motonic. In the older age group only 7 (17.5%) of partici-
pants were normotonic during 24 hr blood pressure mon-
itoring. The proportion of mis-diagnosed normotonic
younger patients was directly related to elevated clinic
blood pressure, which could be referred to as office hy-
pertension or isolated clinic hypertension (white coat hy-
pertension, was statistically significant (c2=5.95; p=0.015).
Similar results to ours were obtained by other au-
thors13,32,33 but their patients were younger (aged up to
18 years, while our patients had an average age range of,
in the younger group (mean ± SD age, 22.8 ± 1.8 years)
and in the older group (mean ± SD age, 50.3 ± 5.7 years).
The results obtained from various studies point out
the necessity of 24 hour CABPM in the evaluation of
white coat hypertension among younger patients13,32–34.
Some studies have shown that the prevalence of white
coat hypertension is more common among borderline
and mild hypertensives, and very rare among moderate
and severe hypertensive patients35. CABPM is useful in
the identification of all types of hypertension and it
should be routinely used in all patients younger than 30
years having possible hypertension10,12,36,37.
Conclusion
Hypertension, diagnosed in younger patients only
based on several occasionally doctor’s office mesura-
ments using mercury sphygmomanometer, could be mis-
-interpreted and treated as the start of arterial hyperten-
sion. This could sometimes have unwanted results due to
the side effects of precipitate antihypertensive medica-
tion as well as unnecessary cost of testing, cost of treat-
ment, prevalence of white-coat hypertension at baseline,
and varying the incidence of new hypertension after the
initial screening. The results indicate a potential savings
of 3–14% for the cost of care for hypertension and a
10–23% reduction in treatment days when ambulatory
blood pressure monitoring is incorporated into the diag-
nostic process11. Therefore CABPM should be used as a
legitimate method in the diagnosing of white coat hyper-
tension, particularly in young age patients. Idetification
of white coat hypertensive patients should be followed by
a search for metabolic risk or organ damage according to
the latest guidelines, and medication should start after an
organ damage or cardiovascular risk assesement2,5,6,26.
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RAZLIKA IZME\U ARTERIJSKOG TLAKA HIPERTENZIVNIH BOLESNIKA MJERENOG U
LIJE^NI^KOJ ORDINACIJI I PROSJE^NOG KONTINUIRANOG 24-SATNOG ARTERIJSKOG
TLAKA MJERENOG KOD KU]E
S A @ E T A K
Cilj istra`ivanja bio je utvrditi postoji li razlika izme|u arterijskog tlaka hipertenzivnih bolesnika mjerenog u lije~ni-
~koj ordinaciji i prosje~nog kontinuiranog 24-h arterijskog tlaka mjerenog kod ku}e. Ukoliko doista razlika postoji,
daljni cilj nam je bio utvrditi da li je ona posljedica tzv. »hipertenzije bijelog ogrta~a«, odnosno »u~inak bijelog ogrta~a«.
U istra`ivanje je bilo uklju~eno 80 hipertoni~ara, podijeljeno u dvije grupe (40 bolesnika u svakoj mla|a dobna skupina
(26 mu{karaca, 14 `ena), i starija dobna skupina (21 mu{karaca, 19 `ena), prosje~ne dobi mla|e skupine (22,8 ± 1,8
god.) i starije dobne skupine (50,3 ± 5,7 god). Bolesnici su uklju~eni ukoliko im je dijagnosticirana esencijalna hiper-
tenzija 1. stupnja prema 2007 ESH/ESC smjernicama, odnosno smjernicama The USA Joint National Committee Gui-
delines (JNC 7, a njih 35 nije lije~eno antihipertenzivima. Svi sudionici pro{li su dvotjedno razdoblje bez medikamen-
tozne terapije. Najprije je arterijski tlak mjeren `ivinim manometrom, nakon 5 minuta mirovanja, sjede}i, a u analizu je
uzeta prosje~na vrijednost dva posljednja mjerenja, nakon ~ega je bolesnicima postavljen ure|aj za kontinuirano mje-
renje arterijskog tlaka (SpaceLabs 90207 device). Kontinuirano mjerenje arterijskog tlaka pokazalo je da 17 bolesnika
mla|e dobne skupine (42,5%), koji su temeljem mjerenja `ivinim manometrom progla{eni hipertoni~arima, su zapravo
normotoni~ni. U starijoj skupini samo je 7 (17,5%) bilo normotoni~no tijekom kontinuiranog mjerenja arterijskog tlaka.
Statisti~ki je bio zna~ajan udio normotenzivnih prema kontinuiranom mjerenje arterijskog tlaka, a koji su ranije pro-
gla{eni hipertenzivnim, bolesnika (c2=5,95; p=0,015), {to je povezano direktno sa povi{enim klini~kim arterijskim
tlakom, a isto mo`e predstavljati izoliranu klini~ki hipertenziju, odnosno hipertenziju bijelog ogrta~a. Povremena mje-
renja arterijskog tlaka standarnom metodom, u ordinaciji, osobito u mla|ih osoba, ~esto mogu dovesti do pogre{ne
interpretacije rezultata i postavljanja dijagnoze hipertenzije, {to kao rezultat ima nepotrebno preuranjeno uvo|enje
antihipertenzivne terapije, {tetne ili ne`eljene posljedice primjene istih, a tako|er dovodi do nepotrebne primjene medi-
cinskih pretraga, tro{ka,u osnovi i do pogre{nog podatka o prevalenciji hipertenzije bijelog ogrta~a. Dosada{nja istra`i-
vanja pokazala su da je mogu}a u{teda 3–14% tro{kova lije~enja hipertenzije i oko 10–23% smanjenja medikamentoznih
dana u bolesnika kod kojih je primjenjeno kontinuirano mjerenje arterijskog tlaka u dijagnosti~ke svrhe11. Stoga kon-
tinuirano mjerenje arterijskog tlaka treba koristiti kao nu`nu metodu u dijagnosticiranju hipertenzije bijelog ogrta~a,
osobito u mla|ih osoba. Po otkrivanju hipertenzije bijelog ogrta~a potrebno je procijeniti metaboli~ki rizike, kao i stu-
panj o{te~enja organa, a lije~enje je potrebno zapo~eti po otkrivanju istih, odnosno prema procijeni kardiovaskularnog
rizika2,5,6.
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